Jill M. Quigley - 09 Nov 2026 Form 4 Insider Report for FILANA THERAPEUTICS, INC. (FLNA)

Reporting relationship: Director
Issuer ticker: FLNA
Reported as of: 09 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Nov 2026, 16:14:26 UTC
Prior SEC filing: 12 Nov 2026
Source filing: View source filing
Reporting owner signature: /s/ Eric J. Schoen by Power of Attorney

Filing notes and source

Key filing fact

Jill M. Quigley filed Form 4 for FILANA THERAPEUTICS, INC. (FLNA) on 12 Nov 2026.

Key facts

This page summarizes Jill M. Quigley's Form 4 filing for FILANA THERAPEUTICS, INC. (FLNA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Nov 2026, 16:14.

Change

Previous filing in this sequence was filed on 12 Nov 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001799780 Primary reporting owner

Quigley Jill M.

Relationship: Director
Address: 6801 N CAPITAL OF TEXAS HWY, BLDG 1, SUITE 300, AUSTIN
Signature: /s/ Eric J. Schoen by Power of Attorney
Signature date: 12 Nov 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FLNA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +53,000
Change %
Price: $0.000000^*
Shares after: 53,000
Date: 09 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 53,000
Exercise price: $0.4900
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests over three (3) years at a rate of 1/36th each month.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .